Evidence map›Paper›PMID 24627599›Full record

ReviewWorld journal of gastroenterology2014

Serrated pathway in colorectal carcinogenesis.

Letícia Yamane, Cristovam Scapulatempo-Neto, Rui Manuel Reis, Denise Peixoto Guimarães

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Letícia YamaneLetícia Yamane, Rui Manuel Reis, Denise Peixoto Guimarães, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14780-000 São Paulo, Brazil.
Cristovam Scapulatempo-NetoLetícia Yamane, Rui Manuel Reis, Denise Peixoto Guimarães, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14780-000 São Paulo, Brazil.
Rui Manuel ReisLetícia Yamane, Rui Manuel Reis, Denise Peixoto Guimarães, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14780-000 São Paulo, Brazil.
Denise Peixoto GuimarãesLetícia Yamane, Rui Manuel Reis, Denise Peixoto Guimarães, Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14780-000 São Paulo, Brazil.
Hospital de Câncer de Barretos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serrated adenocarcinoma is a recently described subset of colorectal cancer (CRC), which account for about 10% of all CRCs and follows an alternative pathway in which serrated polyps replace the traditional adenoma as the precursor lesion to CRC. Serrated polyps form a heterogeneous group of colorectal lesions that includes hyperplastic polyps (HPs), sessile serrated adenoma (SSA), traditional serrated adenoma (TSA) and mixed polyps. HPs are the most common serrated polyp followed by SSA and TSA. This distinct histogenesis is believed to have a major influence in prevention strategies, patient prognosis and therapeutic impact. Genetically, serrated polyps exhibited also a distinct pattern, with KRAS and BRAF having an important contribution to its development. Two other molecular changes that have been implicated in the serrated pathway include microsatellite instability and the CpG island methylator phenotype. In the present review we will address the current knowledge of serrated polyps, clinical pathological features and will update the most recent findings of its molecular pathways. The understanding of their biology and malignancy potential is imperative to implement a surveillance approach in order to prevent colorectal cancer development.

Indexed as

AdenocarcinomaAdenomaAnimalsCell Transformation, NeoplasticColonic PolypsColorectal NeoplasmsCpG IslandsDisease ProgressionDNA MethylationGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseHumansMicrosatellite InstabilityMutationPhenotypeProto-Oncogene ProteinsBRAF protein, humanKRAS protein, humanProto-Oncogene ProteinsProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)ras ProteinsColorectal carcinogenesisCpG island methylator phenotypeMicrosatellite instabilityMutationSerrated pathway

Identifiers

PMID24627599
PMCPMC3949272
OpenAlexW2131760952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.